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Clinical manifestations of malaria  are associated with repeated cycles of mul- 
tiplication of the parasite in the blood, and any prospective immunopr0phylaxis 
needs effectively to control the blood phase of the infection.  Present attempts 
(1-10)  to  identify  parasite  antigens  of potential  value  in  vaccination  against 
asexual blood stages of the human  parasite  Plasmodium falciparum  have impli- 
cated  a  number  of different  parasite  polypeptides.  However,  experimentally 
induced immunity against the blood forms of P. falciparum  is known to have a 
significant  isolate-specific component (1 1-16),  indicating  intraspecies antigenic 
diversity in one or several of the relevant protective antigen(s ) . Furthermore,  in 
endemic  areas,  individuals  naturally  exposed to  the  infection  suffer repeated 
parasitemias and clinical attacks of the disease before any degree of immunity is 
acquired  (17,  18).  The  reasons  for  such  a  slow and  gradual  development  of 
immunity  are  unknown  but  the  pattern  is  consistent  with  the  existence  of a 
variety of antigenically distinct parasite strains to which a human host may need 
to be exposed before he acquires cumulative immunity against the majority of 
the diverse strains present in his environment.  It is therefore crucial to research 
aimed  at  the  development  of  widely  applicable  vaccine  that  the  degree  of 
antigenic  diversity  in  defined  parasite  antigens  is  elucidated.  Moreover,  most 
immunological research on malaria has been carried out with a limited number 
of antigenicaily poorly defined P. falciparum isolates and it is not known how far 
such isolates are  representative  of wild parasite  populations  in  endemic  areas. 
Thus there is a need for a system of immunological classifications of the parasite 
in order to understand how experimental results obtained in the laboratory may 
relate to the situation in the field. 
Recently, we have used a panel of strain-specific monoclonal antibodies (mAb) ~ 
to demonstrate that the species P. falciparum consists of a number of antigenically 
diverse strains.  Some of these strains  may have a  world-wide distribution  (19, 
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20), while substantial antigenic diversity occurs even within parasite populations 
present in a relatively small geographical area (21).  In the present study we use 
some  of the  strain-specific  antibodies  to  identify a  family of structurally and 
antigenically polymorphic proteins of Mr 190,000-200,000.  We show that these 
proteins are essentially the same as a putative protective antigen of P. falciparum 
that is synthesized in schizonts and then processed into several discrete fragments, 
some of which are associated with the Sui-face of merozoites (2-4). We also show 
that this family of proteins is responsible for much of antigenic diversity in P. 
falciparum and propose that it may be poss{ble to devise a system for serological 
classification  of the  parasite  based  on  the  antigenic  polymorphism  of these 
proteins. 
Materials and Methods 
Culture Media and Chemicals.  RPMI 1640 tissue culture medium was supplied by Flow 
Laboratories  Ltd.,  Ayrshire,  Scotland.  Methi0nine-free  RPMI  1640,  Hepes,  sodium 
glutamate, sodium bicarbonate, and antibiotics were obtained from Gibco Europe Labo- 
ratories,  Paisley,  Scotland,  and  fetal  calf serum  from  Seralab  Laboratories,  Sussex, 
England. 
Aminopterin,  hypoxanthine, thymidine, saponin,  tosyl-l.-lysine chloromethyl ketone 
(TLCK), phenylmethylsulfonyl  fluoride (PMSF), dimethyl sulfoxide (DMSO), 2,5-diphen- 
yloxazole (PPO),  2-mercaptoethanoi, Tris, bovine serum albumin (BSA), Staphylococcus 
aureus V8 protease, and S. aureus protein A-agarose were purchased from Sigma Chemical 
Co., St. Louis, MO. BDH Pharmaceuticals Ltd., London, England supplied the following: 
polyethylene glycol 1500,  Nonidet P-40 (NP-40),  sodium dodecyl sulfat  e (SDS), iodoacet- 
amide, acrylamide, N,N'-methylenebisacrylamide, ammonium persulfate, EDTA, EGTA, 
glyCine, bromophenol blue, sorbitol, and glycerol. Radiolabeled L-[35S]methionine (sp act, 
800-1,200  Ci/mmol) was  purchased  from Amersham  International  Ltd., Amersham, 
England. 
Immunoadsorbent-purified rabbit anti-mouse immunoglobulin conjugated with fluo- 
rescein isothiocyanate was obtained from Miles-Yeda Ltd., Rehovot, Israel. Rabbit antisera 
specific for heavy chain isotypes of mouse immunoglobulin were purchased from Litton 
Bionetics, Inc., Kensington, MD. Precipitating sheep anti-mouse IgG and goat anti-human 
IgG antisera were obtained from Scottish Antibody Production Unit, Carluke, Scotland. 
Antimalaria Hybridomas,  mAb,  and Sera.  The procedure  for preparation of mouse 
hybridomas secreting P. falciparum-specific  mAb was as described (19).  Briefly, female 
BALB/c mice were preimmunized with two to four doses of 4-6 ×  106 schizonts (or 100- 
200 #g of protein) obtained from asynchronous parasite cultures lysed by treatment with 
0.15%  (vol/vol)  saponin and were injected intraperitoneally with incomplete Freund's 
adjuvant. The mice were then challenged with similar doses of antigen in saline intrave- 
nously and  3  d  later their spleen cells  were  fused with the  P3/NS-1/1-Ag4-1  (NS-1) 
myeloma (22) in the presence of polyethylene glycol (23). The cells were grown in 2-ml 
volumes of hypoxanthine-aminopterin-thymidine selective  medium, and, after 10-14 d, 
hybridoma cultures producing antiplasmodiai antibodies were identified by indirect im- 
munofluorescence assay  (IFA)  on  acetone-fixed schizonts.  Selected  hybridomas were 
purified by limiting dilution cloning in the presence of BALB/c thymocytes as feeders, 
and the cloned cells were grown as ascites tumors in BALB/c mice, yielding ascitic fluids 
that contained mAb. Isotypes of the antibodies were determined by Ouchterlony double 
diffusion in agar, by reacting 20-fold concentrated culture supernatants against rabbit 
antisera specific for mouse heavy chain classes and subclasses. 
Hybridoma lines were given the prefix EUZ (Edinburgh University, Zoology Depart- 
ment) and a numerical code consisting of the sequential number of fusion experiment 
followed by the number given to a cell line derived from an independent fusion event 
within that experiment. Thus, EUZ 6.1 indicates the cell line No. 1 obtained from fusion 
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cloning and recloning; e.g.,  EUZ 6.1-1-3 indicates clone No.  3 derived by recloning of 
the  cloned  line  EUZ  6.1-1.  mAb were  given  the  same  basic  numerical  codes  as  the 
producer hybridoma lines but without the prefix and, for simplicity, without the numbers 
identifying the clones and subclones, since these were all found to secrete antibodies of 
the same characteristics, such as isotype, and parasite stage and strain specificities etc. 
Antibodies selected for the present experiments were raised in several fusions against 
four different isolates of P. falciparum. Antibodies designated 6.1, 7.3, 7.5, and 7.6 were 
produced  against  isolate  K1;  antibodies  designated  9.2,  9.5,  9.7,  9.8,  and  10.3  were 
against isolate PB 1; and antibodies 12.1,  12.2, and 12.4 against isolate T9. These isolates 
originated  from Thailand.  Reference antibody  89.1  was  raised  against  West  African 
Wellcome isolate and was kindly provided by Drs. R. R. Freeman and A. A. Holder who 
described its properties earlier (2-4). Immune human serum was a pool of five sera from 
adult  residents  of a  malaria  hyperendemic  area,  and  was  kindly  supplied  by  Dr.  A. 
Adjukiewicz of Medical Research Laboratories, The Gambia, West Africa. 
Indirect  lmmunofluorescence  Assays  (IFA).  The  tests  were  performed  at  pH  7.3  as 
described (19, 26-27) on acetone-fixed films of parasitized blood or on unfixed suspensions 
of parasites released from red cells lysed by glycerol treatment (see below). Specificities 
of mAb for different developmental stages of the blood cycle were determined  using 
parasites derived from synchronous cultures (28,  29),  as well as synchronous parasites 
obtained from malaria patients and matured in vitro (20). Gametocytes of P. falciparum 
were obtained from human carriers and were kindly provided by Dr. L. Panton of the 
MRC  Laboratories,  The  Gambia,  West  Africa.  Strain  specificities  of the  mAb  were 
determined using schizonts prepared from a  panel of P. falciparum  isolates originating 
from several endemic areas (see below). 
Isolates ~ and  Clones  of P.  falciparum,  mAb  were  raised  against  uncloned  isolates 
designated K1, PB1, and T9, all of which originated from Thailand (24-26).  From the 
isolate T9 a  number of cloned  parasite  lines  were derived  using the  limiting dilution 
technique (25, 26); four of the clones, designated Nos. 94, 96,  101 and 102, were chosen 
for use in the present study since an earlier investigation had shown them to be phenotyp- 
ically homogeneous and distinct from each other by several criteria, including enzyme, 
protein, and antigen variant markers (26).  These isolates and clones as well as a selection 
of another 42 culture-adapted lines of P. falciparura originating from Asia, Africa, Papua 
New Guinea, and Central  and  South  America, were obtained from the  World  Health 
Organisation  Reference Bank  of Malaria Strains held in  the  Department of Genetics, 
University of Edinburgh. 
In Vitro  Cultivation  of P. falciparum.  The parasites were maintained using the petri 
dish method of continuous cultivation as described by Trager and Jensen (28).  2-4 ml 
cultures  were started at 0.5%  parasitemia in  human group O  erythrocytes added to a 
hematocrit of 5% (vol/vol) into RPMI  1640 medium supplemented with 25 mM Hepes, 
22 mM NaHCOs, 50 #g]ml gentamycin, and 10% (vol/vol) human group A serum. The 
culture medium was changed daily and fresh erythrocytes were used to dilute the cultures 
whenever  the  parasitemia  reached  10-15%,  usually  every  4  d.  These  cultures  were 
asynchronous and  contained all stages of the asexual blood cycle (rings,  trophozoites, 
schizonts, merozoites). For some experiments, cultures at 8-10% parasitemia were syn- 
chronized by the method of Lambros and Vanderberg (29) using one or two cycles of 
treatment with sorbitol as described (2) 
Release of  Parasites from Infected Erythrocytes.  Red cells containing synchronous parasites 
at the schizont stage were lysed by osmotic shock using treatment with glycerol: 1 vol of 
packed cells was resuspended in 25 vol of 7% (vol]vol) glycerol in RPMI  1640  medium 
for 30 min at room temperature, the cells repacked by centrifugation at 500 g for 5 min, 
"Isolate" is used here to refer to a sample of parasites, not necessarily  phenotypically or genetically 
homogeneous,  collected from a naturally infected human  host on a single occasion. The present 
isolates had all been adapted  to growth in vitro and were maintained in the laboratory for periods 
ranging  from a  few  months  to  several  years before this  study;  it  is not  known  whether  their 
composition was the same as the original  samples obtained  from the patients.  "Clone" refers  to 
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the supernatant removed, and the cells lysed by rapid resuspension in 25 vol RPMI 1640. 
This procedure resulted in preparations containing free parasites, red cell ghosts (some 
with parasites trapped inside them), and small  numbers of unlysed red cells.  For immu. 
nizations of mice, parasites were obtained from erythrocytes lysed with 0.15% (vol/vol) 
saponin. Total parasites and multinuclear schizonts were counted using aliquots of the 
above preparations stained with ethidium bromide (0.001% wt/vol in phosphate-buffered 
saline [PBS]), with a hemocytometer and a fluorescence microscope. 
[ssS]MethionineBiosyntheticLabelingofP.falciparum.  The parasites were labeled essen- 
tially as described (2). Erythrocytes containing 2-4 ×  108 parasites, either from asynchro- 
nous cultures (all stages including trophozoites and schizonts) or from cultures harvested 
33 hs after synchronization (mostly early schizonts), were washed twice in methionine- 
free RPMI  1640 prewarmed to 37°C and were then resuspended in 6  ml of the same 
medium, containing  10%  (vol]vol) human  serum  and supplemented with  400  #Ci  of 
[s~S]methionine. The cells in petri dishes were returned to a gassed culture jar and were 
incubated for various periods from 30 min to 6 h. After labeling, the parasitized red cells 
were washed twice in cold PBS, pH 7.2 and were stored as frozen pellets at -70°C before 
extraction. 
Cell Extraction and Immunoprecipitation.  Cell pellets were thawed and extracted on ice 
for 1 h in 5 ml of 1% (vol/vol) NP-40 in buffer containing 50 mM Tris-HCI, pH 8.0, 5 
mM EDTA, 5 mM EGTA, 5 mM iodoacetamide, 1 mM PMSF and 0.1 mM TLCK (2). 
Insoluble material was removed by centrifugation at 100,000 g for 30 min at 4°C. Total 
and protein-bound (insoluble in 5% wt/vol TCA) radioactivity of the extracts was deter- 
mined by scintillation counting in the ~4C channel of a Packard 2407 counter (Packard 
Instrument Co., Downers Grove, IL). Typically, 40-50% of the incorporated label was 
solubilized by the above extraction procedure and >90%  of this was present as TCA- 
precipitable material. 
Aliquots of the labeled extracts containing 1-2 x  10  h cpm were mixed with 20 ~1 of 
mouse ascitic fluids containing mAb or with 20 #1 of human antisera and the mixtures 
were incubated at room temperature for 1 h. Soluble immune complexes were precipitated 
using 300 #1 of sheep anti-mouse IgG or goat anti-human IgG at 4 °C overnight. Antibody 
9.5  (IgG2b)  was  precipitated  using  20  #1  of protein  A-agarose  instead  of the  sheep 
antiserum. The immunoprecipitates were washed three times in 50 mM Tris-HC1, pH 
8.0, 5 mM EDTA, 0.5% NP-40, containing 0.5 M NaC1 and 1 mg/ml BSA, then twice in 
the same buffer without NaCI and BSA (2). For each wash, 2.5 ml of the buffer was used, 
followed by  centrifugation  at  200  g  for  5  min,  resuspension  of the  precipitates  by 
vortexing, and addition of the next wash. The washed complexes were dissolved in 60 #1 
of 125  mM Tris-HCl, pH  6.8,  10% SDS,  5%  2-mercaptoethanol, 2  mM  EDTA,  20% 
glycerol, and 0.25% bromophenol blue, by boiling for 5 min (31). 
SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE).  Immune  complexes containing 
[35S]methionine-labeled parasite  polypeptides were analyzed by SDS-PAGE (30)  using 
7.5%  acrylamide slab  gels  as  described (31).  Molecular weight  markers  were  human 
spectrin heterodimer (240,000 and 220,000 mol wt, a gift from Dr. A. Maddy, Zoology 
Department, University of Edinburgh), phosphorylase b (94,000 mol wt), albumin (67,000 
mol wt),  catalase  (60,000  mol wt),  ovalbumin (43,000 mol wt),  lactate dehydrogenase 
(36,000 mol wt), carbonic anhydrase (30,000 mol wt), and trypsin inhibitor (20,100 mol 
wt), supplied by Pharmacia Fine Chemicals AB, Uppsala, Sweden. After electrophoresis, 
the gels were stained with Coomassie Blue in fixative and treated with 22% (wt/vol) PPO 
in DMSO before drying. Radiolabeled bands were detected by fluorography at -70°C 
(32) using preflashed Kodak X-Omat S film. 
V8 Protease Peptide Mapping.  Washed mAb precipitates containing 2.5 ×  104 cpm of 
[35S]methionine-labeled parasite products were resuspended in  300 #1 of 50 mM Tris- 
HCI, pH 7.5, 0.5% SDS,  10% glycerol, and were then digested with staphylococcal V8 
protease at 60 #g/ml and 37°C as described (33). 50-#1 samples were removed at intervals 
and the digestion was halted by addition of 50 #1 double strength sample buffer (2% SDS, 
100 mM Tris-HCI, pH 7.5, 2 mM EDTA,  10% 2-mercaptoethanol, 4 mM PMSF,  10% 
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12.5% wt/vol acrylamide gels, and peptides containing [35S]methionine were visualized 
by fluorography. 
Results 
Hybridomas  and mAb.  In  12 fusions, >280  hybridomas were generated that 
reacted with different erythrocytic stages of P. falciparum.  Preliminary work (19, 
27, 33 and unpublished data) indicated that some of these antibodies react with 
a  class of mutually  related antigens,  which  were in  many  respects similar  to a 
schizont protein recently described by other workers (2). From this preliminary 
information, mAb produced by 13 different cloned hybridoma lines were selected 
for the present comparative study. Properties of the antibodies are summarized 
in Table I. 
Location  and  Stage  Spec~Jicity of Antigenic  Determinants  ~ Recognized  by  mAb. 
When  tested by IFA on acetone-fixed films of schizonts and merozoites of the 
homologous isolates, all of the antibodies produced an indistinguishable staining 
pattern in reaction with antigen(s) that appeared to be associated with the plasma 
membrane  of these  stages  (Fig.  1).  Furthermore,  the  mAb  reacted  with  the 
surface and caused indirect agglutination of free, unfixed schizonts and,  where 
present, of merozoites released from erythrocytes lysed by osmotic shock.  The 
antibodies  also  reacted  with  pigment-containing  particles  without  a  nucleus, 
which were presumed to be residual bodies remaining after rupture of mature 
TABLE  I 
Summary of Anti-P. falciparum Hybridomas and mAb 
Hybridoma  Antibody  Reactivity in indirect immunofluorescence 
Unfixed 
(:ode  Immunizing  Code  Mouse  Acetone-fixed  blood stages*  parasites*  Isolate 
,  isolate  isotype  distribution! 
S  M  R  T  G  S  M 
EUZ 6,1-1~3  ThaiKl  6.1  lgGl  ++  +  ++  NT  16 
EUZ 7.3-7  KI  7.3  IgG2a  ++  +  ++  ++  16 
EUZ 7.5-1  KI  7.5  lgGI  ++  ++  ++  +  -  ++  NT  46 (17) 
EUZ 7.6-2  KI  7.6  lgGl  ++  +  ++  NT  16 
EUZ 9.2-6-2  Thai PBI  9.2  lgG1  ++  +  ++  ++  30 
EUZ 9.5-1-5  PBI  9.5  lgG2b  ++  +  ++  +  15 
EUZ 9.7-1  PB1  9.7  lgG1  ++  +  +  NT  30 
EUZ 9.8-4-4-1  PB1  9.8  IgGl  ++  +  ++  ++  46 
EUZ 10.3-2  PBI  10.3  lgG1  ++  +  ++  NT  30 
EUZ 12.145-4  Thai T9  12.1  lgG1  ++  -I-  ++  NT  17 
EUZ 12.2-1-1  T9  12.2  lgG1  ++  +  ++  +  14 (7) 
EUZ 12.4-3-4  T9  12.4  lgGl  ++  +  ++  NT  46 
WIC 89.11  West African  89.1  lgGl  ++  +  NT  NT  46 
Wellcome 
* Reactivity with acetone-fixed films of erythrocytic stages: (++, +) relative intensity of positive staining; (-) negative reaction. R, ring forms 
withoui i~igment;  T, mononuclear trophozoites containing dispersed pigment; S, schizonts with four or more nuclei and aggregated pigment; 
M, merozoites; G, gametocytes. 
* Schizonts released from erythrocytes lysed by glycerol treatment as described in Materials and Methods; some preparations also contained 
small mononuclear parasites assumed to be merozoites released from the most advanced schizonts.  NT, not tested. 
I Numbe  r of P. falciparum i~0lates positively reactive out of 46 tested (see Table Ill for details).  Numbers in brackets indicate the'number of 
positive isolates  which gave consistendy only subnormal dull reactions. 
! See reference 2 for details of hybridoma WIC 89.1  and antibody 89.1. 
"Antigenic  site",  "determinant",  and  "specificity"  are  used  here  interchangeably  to  refer  to  a 
regior~ or structure  on  the  antigen  that  is involved  in antibody  binding;  cross-reactivity  of more  than 
one  antigen  with  the  same  monoclonal  antibody  indicates  similarity  but  does  not  prove  identity  of 
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FIGURE l.  indirect immunofluorescence staining pattern produced on acetone-fixed fihns 
of P. falciparum schizonts by all of the mAb used in this present study. The photo shows  two 
segmented schizonts of clone 94, stained with antibody 7.6. 
schizonts.  None of the  mAb  reacted  with  gametocytes or with  the  surface  of 
erythrocytes infected by any of the developmental stages of the parasite. 
All  but one antibody reacted specifically with  schizonts and  merozoites,  but 
did not react with either the preceding (trophozoite) nor the subsequent (ring) 
developmental stages of the asexual blood cycle. This indicated that the antigenic 
sites recognized by these  mAb were formed only during  schizogony and  were 
subsequently lost or degraded around  the time of invasion of new red cells by 
merozoites. 
The  one  exception  was  a  determinant  recognized  by antibody  7.5,  which 
reacted strongly with all asexual blood forms.  In schizonts and merozoites, this 
determinant  seemed to be membrane associated, similar to those recognized by 
the other antibodies, but in rings and trophozoites it appeared to be present also 
in the parasite's cytoplasm. 
Differential IFA Reactivities  of mAb with Clones of P. falciparum.  Four clones of 
P. falciparum,  designated  94,  96,  101, and  102, which were all derived from a 
single  isolate  of the  parasite,  were used to  test  the  mAb for their  capacity  to 
differentiate  between  schizonts  of  the  different  clones.  The  IFA  tests  were 
performed on -104 acetone-fixed schizonts using serial 10-fold dilutions ofascitic 
fluids containing  the mAb.  We examined  the reaction  at  520×  magnification, 
recorded antibody titer (the  highest dilution  still  giving positive reaction),  and 
compared the intensity of staining between schizonts of positively reactive clones 
obtained at  1  : 10 and  1 : 100 dilutions. 
As summarized  in  Table  II,  three'of the  tested  mAb  (9.8,  12.4,  and  89.1) 
reacted equally well with schizonts of all four clones, indicating that the clones 
shared common antigenic determinants operationally defined by these reagents. 166  POLYMORPHISM  OF  SCHIZONT  ANTIGEN  OF PLASMODIUM FALCIPARUM 
TABLE  II 
Summary of Reactivities of Four Clones of P. falciparum with mAb Directed Against Different 
Determinants of the High Molecular Weight Schizont Antigen 
Antibody  e 
Immunofluorescenc  e Iog~o titer*  Immunoprecipitation* 
Parasite clone  Parasite clone 
94  96  101  102  94  96  101  102 
89.1  (1)  4  4  4  4  ++  ++  ++  ++ 
9.8  (2)  5  5  5  5  ++  ++  ++  ++ 
12.4  (3)  4  4  4  4  ++  ++  +  + 
7.5  (4)  4  3  3  3  ++  +  -  - 
6.1  (5)  4  -  -  -  ++  -  -  - 
7.3  (6)  6  -  -  -  ++  -+  -  - 
7.6  (7)  5  -  -  -  ++  -  -  - 
9.2  (8)  -  5  5  5  -  ++  ++  ++ 
9.7  (9)  -  5  5  5  -  ++  ++  + 
10.3 (10)  -  5  5  5  -  ++  ++  ++ 
9.5 (11)  -  -  5  -  -  -  ++  - 
12.2 (12)  -  6  -  3  -  ++  -  + 
12.1 (13)  -  5  -  5  -  ++  -  ++ 
* IFA titers are expressed as logs of the reciprocal of the highest dilution giving a positive reaction 
using ~104 schizonts per test; e.g.,  1:10 =  1;  1:100 =  2. Negative reactions at 1:10 and all other 
dilutions are shown as (-). Positive but subnormal dull reactions of some antibodies are italicized. 
* Reactivity with high molecular weight polypeptides (195,000-200,000) was determined for each 
clone and antibody combination in at least three separate experiments. (+ and ++) Consistently 
positive results; (_) weak reactions in some but not in all experiments. See Fig. 2 for representative 
examples of SDS-PAGE analysis. 
0 Numbers in parentheses correspond to the coding of lanes in Fig. 2, which shows an analysis of 
precipitates obtained with the mAb. 
The  other  10  antibodies  clearly revealed  the existence of specificites that  were 
expressed  in  some  but  not  all  parasite  clones,  and  such  determinants  will  be 
termed  "restricted" in this study. The ability to differentiate between the parasites 
was most striking for antibodies 6.1,  7.3,  7.6,  9.2, 9.5, 9.7,  10.3,  12.1, and  12.2, 
which  reacted  with certain clone(s) up to at least a  1:10,000  dilution but  failed 
to  give  any  detectable  reaction  with  schizonts  of other  clone(s).  We  interpret 
these  different  reactions  in terms  of the presence  and  absence,  respectively,  of 
antigenic  determinants  recognized  by these  mAb.  In addition,  antibodies  12.2 
and  7.5  produced  positive  reactions  that  differed  in  strength  between  certain 
clones. For example,  mAb  12.2, which stained schizonts of clone 96 brightly and 
titrated to  1:1,000,000  with these parasites, had to be used in at least  1,000-fold 
higher  concentration  to  produce  a  detectable,  but  weak,  reaction  with  mature 
schizonts of clone  102.  Such different  reactivities are assumed  to reflect differ- 
ences  in  avidity of binding  of these  mAb  to  similar but  not  identical  antigens 
expressed  by schizonts of the different clones. 
In Vitro Stability of Antigenic Phenotypes of Cloned P. falciparum.  Each  of the 
parasite  clones could be distinguished  (Table  II) from  the others  by its charac- 
teristic combination  of mAb-defined  specificities or antigenic serotype.  Stability 
of the clonal serotypes was tested by repeated  IFA typing on schizonts sequentially 
harvested  from long-term  continuous  cultures, as follows: clone 94 was tested 35 
times over  a  period  of 39  mo  in vitro; clone  96  was  typed  29  times during  20 McBRIDE,  NEWBOLD,  AND  ANAND  167 
too; and clones 101 and 102 were tested four and nine times, respectively, in 17 
too.  Reactivities of all  clones with all  of the antibodies remained unchanged 
during these periods. In addition, within the limits of the technique (19, 26), all 
of the clones appeared to remain homogeneous, containing either positively or 
negatively reactive schizonts but not mixtures of both. Thus we conclude that 
the variant serotypes, as determined in IFA by the mAb are phenotypicaily stable 
characteristics of P. falciparum clones grown under standard in vitro conditions. 
Differential Immunoprecipitation by mAb of High Molecular Weight Antigens Pro- 
duced by Clones of P. falciparum.  The differential patterns of reactivity of the 
antibodies with the clones 94, 96, 101, and 102 were confirmed, and molecules 
carrying the respective antigenic sites were identified by indirect immunoprecip- 
itation. For these experiments, synchronous cultures containing early schizonts 
were biosynthetically pulse-labeled with [SSS]methionine, and labeled antigens 
were then extracted in NP-40 and precipitated with the mAb. The precipitates 
were analyzed by SDS-PAGE and the labeled parasite polypeptides were visual- 
ized by fluorography. 
Fig. 2 shows precipitation of antigens labeled for 150 min; comparable results 
were obtained after a pulse of 30 min (not shown). Each of the parasite clones 
synthesized a major high molecular weight polypeptide at (195,000-200,000 Mr) 
that was recognized by several mAb (Fig.  2,  lanes 1-13) as well as by human 
immune serum (lane IS). Although the products of different clones were immu- 
nologically related, as shown by cross-reactions of some antibodies with all of 
them (Fig. 2, lanes 1-3), they were not antigenically identical and each presented 
a  characteristic pattern of reactivities with antibodies directed against the re- 
stricted determinants (lanes 4-13). Thus, the antigen produced by clone 94 was 
precipitated by antibodies 7.5, 6.1,  7.3, and 7.6 (Fig. 2, lanes 4-7) but not by 
antibodies  9.2,  9.7,  10.3,  9.5,  12.2,  and  12.1  (lanes 8-13,  respectively).  In 
contrast, the specificities that characterized the product of clone 94 were recog- 
nized poorly (mAb 7.5, Fig. 2, lane 4) or were not detectable on the products of 
clones 96,  101, and 102. Instead, the antigens of all the later clones expressed 
specificities defined by antibodies 9.2,  9.7,  and  10.3  (Fig.  2,  lanes 8-10),  and 
could be distinguished from one another by the presence of determinants defined 
by antibodies 9.5 (lane 11, clone 101), or 12.2 (lane 12, clone 96)and/or 12.1 
(lane 13, clones 96 and 102).  The immunoprecipitation results are summarized 
and compared with those of the immunofluorescence studies in Table II. The 
results are in good agreement and strongly indicate that, although immunologi- 
cally related, the high molecular weight schizont polypeptides display antigenic 
polymorphism between clones of P. falciparum.  They will therefore be termed 
polymorphic schizont antigens (PSA). 
Identity of Polypeptides Precipitated by mAb of Different Specificities from the Same 
Parasite Clone.  In  the above  experiments all  of the antibodies that  reacted 
positively with a  given parasite  clone appeared  to  react  with the  same  high 
molecular polypeptide also  recognized  by  mAb  89.1  (Fig.  2,  lane  1).  This 
antibody had been previously used (2) to identify an antigen that is posttransla- 
tionally processed  into  a  series  of well-defined smaller  fragments.  Since  the 
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antibodies directed against the different stage-restricted and/or parasite clone- 
restricted determinants also recognized the processed polypeptides. 
Fig. 3 illustrates that, from extracts of asynchronous cultures, identical patterns 
of multiple bands  were  precipitated  by antibodies recognizing strain-common 
(lane 3) and strain-restricted (lane 4) specificities limited to schizonts, or those 
present throughout the asexual cycle (lane 2).  The banding pattern  obtained, 
reproducibly, from extracts of clone 94  in six experiments included the major 
band at Mr  195,000,  a  doublet  or triplet at Mr  156,000,  a  single band at Mr 
76,000, and a band at about Mr 32,000 (the smallest band seemed to be displaced 
by the large amounts of immunoglobulin light chains that migrated just ahead 
of it).  In some experiments a  weak band at Mr  110,000  was also present (not 
shown). From clone 94, this characteristic pattern of polypeptides was identically 
precipitated by all antibodies known to react positively with this clone, i.e., mAb 
6.1, 7.3,  7.5, 7.6, 9.8,  12.4 and, with the exception of the smallest (Mr 32,000) 
species,  also  by  mAb  89.1,  strongly  indicating  that  all  of  these  antibodies 
recognized the same antigen and its processed products. In contrast, none of the 
polypeptides  were  recognized  in  extracts  of clone  94  by  antibodies  against 
specificities absent from this clone (e.g., mAb 9.2, Fig. 3, lane 5; see Table II for 
the others), or by control mAb directed against a  variety of other parasite and 
nonparasite antigens, nor by nonimmune mouse and human sera (not shown). 
Similar results (not shown) were obtained using restricted mAb 9.2, 9.7,  10.3, 
12.1,  12.2  and  the  three  anti-common  mAb  in  immunoprecipitations  from 
extracts of clones 96 and  101, and uncloned isolate PB 1. The combined results 
can be summarized as follows: (a) From any given extract, the same pattern of 
bands was precipitated by those antibodies that reacted positively with the parasite 
line  tested,  and  these  bands  were  not precipitated  by the  control,  negatively 
reactive reagents.  The  apparently  identical Mr  of the  major as  well as of the 
minor bands precipitated from extracts of a  single parasite line, by antibodies 
directed against different determinants of PSA, indicated that the common and 
restricted sites were present on the same polypeptides. (b) The banding patterns 
consisted of the large antigen at Mr 190,000-200,000  and, usually, of additional 
polypeptides  at  approximately  Mr  155,000-165,000,  75,000-85,000,  and 
30,000-33,000.  There  was some variation in the apparent  sizes of the bands, 
depending on the different parasite lines from which they originated (see below 
and  Fig.  5).  (c)  Antibody  89.1,  which  cross-reacted  with  the  products  of all 
parasite lines tested, recognized, with the exception of the smallest (Mr 30,000- 
33,000) peptides, the same banding patterns as the other antibodies used in the 
FIGURE 2.  Parasite  clone-specific  patterns ofimmunoprecipitation of high molecular weight 
schizont antigens by mAb directed against strain-common  (lanes 1-3) and strain-restricted (4- 
13) antigenic determinants. Synchronous cultures ofP. falciparura clones 94, 96, 101, or 102 
contained mostly schizonts and were labeled with [sSS]methionine  for 150 min. Immunopre- 
cipitates by mAb were compared with peptides precipitated by human immune serum (IS) 
from NP-40-soluble parasite extracts (EX). Lanes 1-13 were loaded with equal volumes (30 
#1) of dissolved precipitates obtained with mAb 89.1, 9.8, 12.4, 7.5, 6.1, 7.3, 7.6, 9.2, 9.7, 
10.3, 9.5, 12.2, and 12.1, respectively.  SDS-PAGE  analysis  in 7.5% acrylamide  gels. Molecular 
weight markers are indicated on the right: human spectrin heterodimer (240,000 and 220,000 
mol wt), BSA (67,000), catalase (60,000), and lactate dehydrogenase (36,000). (Weak bands 
visible at ~55,000 mol wt, particularly on gels of clones 101 and 102, are considered to be 
due to material  nonspecifically  co-migrating  with  the large  amounts  of  the heavy  chains  of  gamma- 
globulin present in the immunoprecipitates.) 170  POLYMORPHISM  OF  SCHIZONT  ANTIGEN  OF  PLASMODIUM  FALCIPARUM 
FIGURE 3.  [s~S]methionine-labeled  polypeptides immunoprecipitated by antibodies of differ- 
ent stage and strain specificities (lanes 2-5) from the NP-40-soluble fraction of clone 94 (lane 
1). (Lane 2) Products precipitated by the antibody 7.5,  which  reacts with  all asexual blood 
stages (schizonts,  merozoites, rings, trophozoites). (Lanes 3 and 4) Precipitates obtained with 
two antibodies, mAb 12.4 and 7.6, respectively, which react only with schizonts and merozoites; 
while  the former mAb reacts with a determinant present on all strains of P. falciparura,  the 
latter defines a strain-restricted specificity.  In contrast, the antibody 9.2, which recognizes a 
different strain-restricted antigenic determinant absent from clone 94, precipitates no antigen 
from this  parasite and is used here as a  negative control (lane 5).  SDS-PAGE  analysis on a 
7.5%  gel and fluorography of polypeptides labeled in asynchronous culture during a period 
of 6 h.  Molecular weight markers are indicated on the right:  human spectrin heterodimer 
(240,000  and  220,000  tool  wt)  BSA  (67,000),  catalase  (60,000),  lactate  dehydrogenase 
(36,000).  The estimated relative molecular weights (x 10  s) of polypeptides specifically precip- 
itated by the mAb are indicated on the left. 
present study. As shown previously (2), the peptides at approximately Mr 155,000 
and  80,000,  recognized  by  mAb  89.1,  were  probably  derived  from  the  Mr 
195,000-200,000  precursor,  but  the  identity  of the  smallest  species  remains  to 
be elucidated. 
An  additional  experiment  established  that,  as  indicated  above,  common  and 
restricted  variant  antigenic  sites  were  indeed  present  on  the  same polypeptide. 
In  this  experiment,  the  [s~S]methionine-labeled,  Mr  200,000  product  of clone 
102  was precipitated  by either  mAb  9.8  or  9.2,  which  recognize  common  and 
restricted  epitopes,  respectively.  The  precipitates  were  digested  with  staphylo- 
coccal V8 protease for various periods,  and the digestion peptides obtained from 
the  two  precipitates  were analyzed  in  parallel  by SDS-PAGE  (Fig.  4).  Although 
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FIGURE 4.  Peptide  mapping of antigens  precipitated  from  the  same  single parasite  clone 
(No.  102) with antibodies against a  strain-common (mAb 9.8,  lane 1) and a strain-restricted 
(mAb  9.2,  lane  2)  determinants.  The Mr  200,000  antigen  of clone  102  was  labeled  with 
[35S]methionine for 150 min and was precipitated from NP-40 extract by either antibody. The 
precipitates were digested with staphylococcal V8 protease at 60 gg/ml for various times as 
indicated, and digestion peptides were analyzed in one dimension by SDS-PAGE on a  12.5% 
gel. Labeled products were detected by fluorography. Patterns of the digestion peptides from 
the two precipitates were identical, showing that both antibodies reacted with the same antigen. 
digestion of both precipitates progressed identically, yielding an indistinguishable 
pattern  of fragments.  This  finding is  consistent with  both  the common and 
variant determinants being located on the same molecule. 
Differences in the Relative Molecular  Weight and Peptide Composition of the Poly- 
morphic  Schizont  Antigens  Produced  by  Different  Clones of P. falciparum.  The 
apparent molecular weights of PSAs produced by synchronous schizonts of clones 
94 or 96 during a 4-h labeling with [S~S]methionine were directly compared by 
parallel SDS-PAGE analysis (Fig.  5).  Both parasite clones contained the large 
polypeptide and  also  several  additional  bands  that  were precipitated  by  the 
antibody 9.8  cross-reactive with both  clones (Fig.  5,  lanes 3,4),  by antibodies 
against epitopes restricted to clone 94 or 96, respectively (lanes 2 or 5), and by 
antibodies  present  in  human  immune  serum  (lanes  1  and  6).  The  relative 
molecular weights of the polypeptides precipitated from clone 94 were estimated 
at Mr  195,000  (major),  156,000  (weak doublet), 76,000  (weak),  and ~32,000, 
while the analogous polypeptides precipitated from clone 96 were Mr 200,000, 
165,000,  80,000,  and  33,000.  (The  intermediate  peptides,  while  visible  on 
examination of the autoradiograph, are not readily detectable on the printed 
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FIGURE 5.  Comparison  of relative molecular weights of polypeptides immunoprecipitated 
from P. falciparura clones 94 or 96 with schizont-specific mAb and with human immune serum 
(lanes  1,6).  (Lanes 2 and 5) Precipitates from extracts of clone 94 or 96 by strain-restricted 
mAb  7.3  or  9.2,  respectively.  (Lanes  3  and  4)  Precipitates  with  mAb  9.8  against  a  PSA 
specificity common to both clones. SDS-PAGE analysis  in 7.5% gel and fluorography of NP- 
40-soluble peptides labeled with [3SS]methionine during a period of 4 h in synchronous cultures. 
The relative molecular weights of bands precipitated by the mAb from clone 94 were 195,000 
(major),  156,000  (weak doublet),  76,000  (weak),  and  32,000,  while the analogous bands  in 
clone 96 were Mr 200,000,  165,000,  80,000, and 33,000.  Peptides of these relative sizes were 
also precipitated by immune serum  (lanes  1,6).  (The intermediate peptides were detectable 
upon examination of the autoradiograph but are not readily detectable in the printed figure.) 
The major Mr  195,000 and 200,000 products of the parasite clones 94 and 
96,  respectively, were  compared further  by  examination of one-dimensional 
maps of fragments obtained after their digestion with staphylococcal V8 protease. 
To avoid  the  complicating presence of the  natural  processed fragments,  the 
antigens produced by synchronous immature schizonts were pulse-labeled with 
[35S]methionine for 30 min. The cross-reactive antibody 9.8 was used to precip- 
itate both antigens, the precipitates digested for various times with staphylococcal 
V8 protease, and the digestion peptides derived from the two clonal products 
were then analyzed in parallel by SDS-PAGE (Fig.  6). Although some digestion 
peptides of similar  mobility were  obtained  from both antigens,  suggesting a 
common conserved structure,  many of the bands were different for  the two 
antigens, indicating a significant degree of structural diversity between analogous 
products of the two P. falciparum clones, both derived from the same single 
isolate. A comparable degree of diversity of V8 protease digestion fragments was McBRIDE,  NEWBOLD,  AND  ANAND  173 
FIGURE 6.  Comparison  by peptide  mapping  of the high  molecular  weight antigens  from 
parasite clones 94 and 96. The clones were grown, synchronized, and then labeled in parallel, 
when most parasites were at the schizont stage, with [sSS]methionine for 30 min. Antibody 
9.8, which reacts with both parasites, was used to precipitate their PSA from NP-40 extracts. 
The precipitates were digested with staphylococcal V8 protease at 60 ttg/ml for various times 
and the digestion products were analyzed by SDS-PAGE on a 12.5% gel. Labeled bands were 
visualized by fluorography.  Lanes are alternately for digests from clone 94 (1) and clone 96 
(2) obtained at 0, 30 s, 90 s, 5 min, and 30 min. The patterns of digestion peptides derived 
from the cross-reactive antigens produced by different parasites are not identical. 
also  found  between  the  serologically  distinct  Mr  200,000  (indistinguishable  by 
size) polypeptides produced  by the  clones  96  and  101,  also both derived  from 
the same isolate (results not shown). (Note that in control experiments comparing 
V8  protease  peptides  derived  from  the  same  clonal  product  precipitated  by 
different antibodies,  the digestion profiles were identical;  e.g., Fig.  4.) 
Indirect  Immunofluorescence  Typing  with  Anti-PSA  mAb  and  PSA  Serotypes of 
Different Isolates ofP. falciparum.  To confirm and extend the findings obtained 
with  the  four  clones  derived  from  isolate  T9,  the  distributions  of anti-PSA 
specificities on a panel of 37 uncioned isolates and five additional clones (derived 
from T9 as well as from other isolates) were determined by IFA. The results are 
presented in Table III. 
The  antibodies  9.8,  12.4,  and  89.1  reacted  positively  with  all  isolates  and 
within each isolate appeared to react with most if not all multinuclear schizonts, 
thus confirming the existence of conserved determinants on all PSAs. Antibodies 
9.8  and  12.4  were thereafter used to estimate the numbers of mature parasites 174  POLYMORPHISM  OF  SCHIZONT  ANTIGEN  OF  PLASMOD1UM FALCIPARUM 
TABLE  III 
Indirect Immunofluorescence Reactivity of Anti-PSA mAb with P, falciparum Isolates 
K 1, T9/94, 
T9/105, K31, 
K34, T22,  T9/101, PBI,  K29,  MADI3, 
Monoclonal  SL3, NF58,  PB1]I, SKI5,  MAD20,  NF54/C,  T9/96, $3,  T9/102, PBI/3, 
MAD21,  TZ,  Palo Alto, $2  SKI8, SKI9 
antibody  IM2, It, HI,  SKI6, SK17  MAD22,  LES/P9  NF7  T21, K36 
M23, FCB-I  K28, G1, T9  MAD27,  FCQ27 
Wellcome, 
BW, RFCR-3 
89.1  +++  +++  +++  +++  +++  +++  +++ 
9.8  +++  +++  +++  +++  +++  +++  +++ 
12.4  +++  +++  +++  +++  +++  +++  +++ 
7.5  +++  +/+++  +/+++  +++  +  +  +/+++ 
6.1  +++  .... 
7.3  +++  ..... 
7.6  +++  ..... 
9.2  -  +++  +++  +++  +++  +++  +++ 
9.7  -  +++  +++  +++  +++  +++  +++ 
10.3  -  +++  +++  +++  +++  +++  +++ 
9.5  -  +++  +++  -  -  - 
12.2  -/+  -  -  +++  +++  +  -/+ 
12.1  -  --  +++  +++  -  +++ 
PSA serotype  I  11  III  IV  V  VI  VII 
Isolates  and clones  are  shown  as isolate/clone.  Absence  or presence  of reaction  is indicated by  -  or  +++,  respectively;  (+)  positive but 
consistently  subnormal weak reactivity  of some antibodies with certain isolates (see text and Table II); (-/+) some isolates within the group 
were negative while others weakly cross-reacted.  Most isolates were tested at least three times using schizonts harvested from continuous culture 
at weekly intervals;  the Wellcome isolate and clones NF54/C and LE5/P9 were each tested once using acetone-flxed  antigens provided by Drs. 
R. R. Freeman,J.  H.  Meuwissen, and R. Carter, respectively.  In every test,  104 schizonts were screened  for reactivity  with each antibody.  A 
majority of the isolates appeared to be homogeneous, i.e., on reaction  with any one antibody, most parasites  reacted  either positively or not at 
all. The uncloned isolates NF58, T9, PBI, SKI6, T21, and K36, however,  were not homogeneous and, as detected by at least one antibody in 
each case, consisted of mixtures of a majority of nonreactive organisms and a minority (< 10%) of positively reactive  parasites. These six isolates 
are grouped according to the antigenic phenotype of the predominant parasite  population. 
containing PSA and  served as positive controls to  compare with reactions of 
antibodies differentiating between restricted variant epitopes. Most isolates ap- 
peared to consist of homogeneous populations containing schizonts that reacted 
well with the control and some restricted antibodies but which lacked specificities 
detectable by other reagents. However, six isolates were heterogeneous, contain- 
ing a minority of schizonts reacting positively with at least one restricted antibody 
among a  majority of nonreactive ones;  these isolates were considered (in  the 
cases of isolates T9 and PB 1, shown formally by cloning) to be mixtures of more 
than one antigenically distinct clone. Such mixed isolates are grouped in Table 
III according to serotypes of the predominant subpopulations. With this qualifi- 
cation,  each  isolate  could  be  allocated to  one  of seven  groups,  termed  PSA 
serotypes, which were defined operationally as distinct combinations of restricted 
specificities recognized by nine mAb.  Thus,  serotype I  was  characterized by 
positive reactivity with  mAb 6.1,  7.3,  and  7.6  and  the absence of detectable 
reactions with  mAb 9.2,  9.7,  10.3,  9.5,  12.2,  and  12.1.  Serotypes II-VII all 
lacked the marker specificities of type I and shared the determinants defined by 
mAb  9.2,  9.7,  and  10.3.  Serotypes  II  and  III  both  reacted  with  prototype 
antibody 9.5 and lacked specificity 12.2, but could be differentiated by negative 
or positive reactions, respectively, with mAb 12.1. Conversely, serotypes IV and 
V both carried the 12.2 marker and lacked reactivity with mAb 0.5, and could 
be distinguished from each other by reactivity with antibody 12.1. Serotypes VI 
and VII were negative or positive, respectively, with mAb 12.1, did not express McBRIDE,  NEWBOLD,  AND  ANAND  175 
the marker defined by mAb 9.5, and reacted weakly or not at all with mAb 12.2. 
This classification of PSA has proved useful for identification of laboratory and 
field isolates of P. falciparum  (manuscript in preparation) but is not considered 
final and will doubtless be expanded and more extensively defined in the future 
by the use of additional anti-PSA antibodies on larger panels of P. falciparum 
isolates. 
Discussion 
In previous reports, we have demonstrated that mAb specific for schizonts and 
merozoites of the human malaria parasite P. faleiparum  recognize considerable 
antigenic diversity among culture-adapted (19) and clinical (20,  21) isolates of 
the  parasite.  Our  aim  has  been  to  identify  and  characterize  the  molecules 
responsible  for  the  diversity,  and  here  we  describe  a  family of polymorphic 
schizont antigens (PSA) of Mr  190,000-200,000  that significantly contribute to 
antigenic heterogeneity within the causative pathogen of malignant malaria. 
Since uncloned isolates of P. faleiparum frequently contain mixtures of genet- 
ically diverse organisms (see ref. 34 for review), in the present analysis we have 
preferred to use genetically distinct (26) and, at least with respect to the antigens 
studied, phenotypically homogeneous and stable clones of the parasite.  Using 
four such clones as a  source of [35S]methionine-labeled proteins, we show that 
schizonts of each clone synthesize an analogous antigen that may vary moderately 
in size between the clones, and which is recognized by pooled human immune 
serum and, more selectively, by 13 mouse mAb. 
The serological reactivities  of clonal  PSA,  as demonstrated by comparative 
immunoprecipitation and immunofluorescence, have several implications. Firstly, 
PSA of all four clones originating from Thailand share determinants recognized 
by some monoclonal reagents, including the antibody 89.1, which had been used 
previously to identify an Mr 195,000 antigen of a  West African isolate (2).  The 
shared specificities were detected by IFA in every culture-adapted isolate studied, 
regardless of its geographical origin (Table  III;  19) as well as in >200  clinical 
isolates  from  Africa  and  Brazil  (McBride  and  Walliker,  unpublished results). 
These findings strongly indicate  that  PSA of all  clones of P. faleiparura  have 
related or identical common regions in their structure,  as is also indicated by 
certain  limited similarities between their proteolytic digestion profiles (Fig.  6; 
33). Furthermore, since in living parasites PSA seem to be specifically processed 
into a series of discrete fragments, similar in number and related in size between 
clones (2;  Fig.  3),  it seems likely that they all share structure(s)  susceptible to 
cleavage  by  specific  parasite  protease(s).  The  shared  antigenic  determinants 
recognized by the present mAb were species specific, since none of the antibodies 
cross-reacted in IFA with schizonts ofP. vivax or the rodent parasites P. yoelii, P. 
berghei,  P.  chabaudi,  P.  killicki,  or P.  vinckei  (results  not  shown).  Thus,  these 
species-specific determinants are additional to those shown to be shared between 
a Mr  195,000  PSA of P. falciparum  and analogous antigens of P. yoelii and P. 
chabaudi (35). 
Secondly, PSA expressed by different clones of P. falciparum are not identical 
and display antigenic (Fig.  2;  Tables  II,  III) as  well as structural  (Fig.  6;  33) 
polymorphism. Thus in addition to the common structure(s),  the PSA of each 176  POLYMORPHISM  OF SCHIZONT ANTIGEN OF PLASMODIUM  FALCIPARUM 
clone carries, and can be distinguished by, antigenic determinants that are not 
detectable on PSA of certain other clones. Distributions of reactivities of anti- 
bodies recognizing the polymorphic part(s) of PSA of a panel of parasite isolates 
(Table III) indicate that the mAb used in this study recognize a minimum of five 
different specificities, and that these specificities probably belong to three non- 
overlapping segregating sites.  None of the specificities are unique to a  single 
isolate,  but  their segregation does not appear  to  be random,  suggesting that 
certain combinations of determinants are mutually exclusive and may represent 
markers of alternative, possibly allelic forms of PSA.  In the present study we 
have identified seven antigenically distinct forms of PSA. Our preliminary results 
with an extended panel  of mAb against restricted determinants indicate that 
some 10-20 immunologically distinct PSA exist. This is a minimum estimate and 
the full extent of the polymorphism is unknown. It seems likely that a serotyping 
system based on the antigenic composition of PSA could be developed to help 
identify P. falciparum  'strains'  for epidemiological, genetic, and immunological 
use. 
The biological and immunological significance of PSA and their polymorphism 
remains to be determined. In living schizonts they are processed into fragments, 
of which three (Mr 83,000,  42,000, and 1O,000)  have been shown to be present 
as the major components on  the surface of merozoites (3,  4).  The antigenic 
composition of these fragments may not be identical and it seems likely that each 
can play a different biological and/or immunological role. The fragments at Mr 
75,000-85,000  reacted with all antibodies used in this work, indicating that they 
carried  both  common  and  polymorphic  specificities.  With  the  exception  of 
antibody 89.1  (a common determinant), the reagents also precipitated a peptide 
at Mr 30,000-33,000  from extracts of our P. falciparum  lines.  Since the mAb 
89.1 also failed to react with an Mr 42,000 fragment of the antigen from another 
parasite (4),  it is possible that this fragment and our smallest molecular weight 
species are analogous,  the apparent  difference in  size being due to  variation 
between isolates. Alternatively, the small peptide could be an as yet unreported 
fragment of PSA or an unrelated parasite protein specifically associated and thus 
coprecipitated with PSA. 
As discussed elsewhere (2,  35), the PSA of P. falciparum  shares a number of 
biological and immunological similarities, including antigenic polymorphism (33) 
with  products  of several  species  of animal  malaria  parasites  that  have  been 
implicated as  protective antigens  of these  species.  It  was  suggested  that,  by 
analogy, it  may be possible  to  immunize against human malaria  using the P. 
falciparum  antigen  (2)  described  here as  PSA.  This  expectation seems to  be 
supported by the results of a  study (36) in which Saimiri  monkeys were partly 
protected by immunization with a purified P. falciparum antigen corresponding 
to the description of PSA. If these results are confirmed, it will be essential to 
determine the relative importance of immune responses against the common vs. 
polymorphic sites of PSA, in order to assess the feasibility of developing a vaccine 
based  on  this  antigen.  In  addition,  such  assessment  should  logically  include 
investigations on the antigenic structure of PSA in different populations of P. 
falciparum in the main endemic areas (20, 21). 
A  final comment should be made on the use of 'homologous' and 'heterolo- McBRIDE, NEWBOLD, AND ANAND  177 
gous' isolates of P. falciparum in immunological and particularly in protective or 
vaccination experiments.  Such studies  have often yielded inconsistent results, 
providing apparent evidence for strain specificity of protection in some combi- 
nations of parasite isolates but not in others (11-16, 37-41). In these studies the 
terms  homologous  and  heterologous  have  been  assumed  to  imply  antigenic 
identity and probable nonidentity, respectively, between parasites used for im- 
munization and subsequent challenge. Since a single isolate can contain antigen- 
ically different clones (Table II), it is likely that such a  mixed population  may 
change in composition, e.g., under the selective pressure of immune response, 
and thus even a so-called homologous challenge may not be antigenically identical 
to the immunizing inoculum. Conversely, since some antigenically distinct para- 
sites have wide geographical distribution (Table III; 19) it is not unlikely that by 
chance alone,  an  isolate  chosen as  heterologous will  have a  similar antigenic 
composition as the homologous one. With the progress made and the potential 
for immunological classification of P. falciparum,  it seems no longer justified to 
select parasite material for comparative immunological studies by ad hoc criteria 
such as origin, rather than by the at least partly known antigenic composition of 
defined parasite products, such as PSA or other, so far less extensively investi- 
gated, variant molecules (8,  19, 42, 43). 
Summary 
Intraspecies  antigenic  diversity  in  the  blood  stages  of the  human  malaria 
parasite Plasmodium  falciparum  was  investigated using a  collection of murine 
monoclonal antibodies and clones of the parasite. The results were as follows: (a) 
The schizont and merozoite stages of the parasite express on their surface clonally 
restricted antigens detectable by strain-specific antibodies in indirect immunoflu- 
orescence tests. (b) These restricted antigens are phenotypically stable character- 
istics of clones grown in vitro. (c) The molecules carrying the specific antigens 
were isolated by immunoprecipitation and were found to be parasite proteins 
ranging in size from Mr  190,000  to  200,000  between clones. (d) Comparative 
immunoprecipitation and peptide mapping of these molecules showed that each 
parasite clone expresses a  protein that is antigenically and structurally distinct 
from the equivalent products of several other clones. (e) The different clonal 
products are, however, immunologically interrelated, since they possess deter- 
minants in common with all tested isolates of the parasite. (f) These polymorphic 
molecules are closely related to a  previously described schizont protein  of P. 
falciparum  that  is  posttranslationally  cleaved  into  fragments  located  on  the 
merozoite surface. 
These findings show the existence of a family of related polymorphic schizont 
antigents  (PSA) of P. falciparum,  whose expression  is  clonally restricted, and 
indicate that these proteins have regions of constant and variable antigenicity. 
We propose that a system of immunological classification of theparasite can be 
developed based on the polymorphism of these proteins. 
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